[Articles] Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in th
Temozolomide alone is non-inferior to radiotherapy alone in the treatment of elderly patients with malignant astrocytoma. MGMT promoter methylation seems to be a useful biomarker for outcomes by treatment and could aid decision-making.
No comments:
Post a Comment